|
|
|
MIRA INFORM REPORT
|
Report No. : |
509487 |
|
Report Date : |
24.05.2018 |
IDENTIFICATION DETAILS
|
Name : |
ZUVENTUS HEALTHCARE LIMITED |
|
|
|
|
Formerly known
as : |
ZUVENTUS HEALTHCARE PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
T-184, M.I.D.C., Bhosari, Pune – 411026, Maharashtra |
|
Tel. No.: |
91-20-27120084 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2017 |
|
|
|
|
Date of
Incorporation : |
27.05.2002 |
|
|
|
|
Com. Reg. No.: |
11-018324 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
INR 200.552 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U85320PN2002PLC018324 |
|
|
|
|
IEC No.: [Import-Export Code No.] |
3105001191 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
Not Available |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACZ1513C |
|
|
|
|
GSTN : [Goods & Service Tax
Registration No.] |
Not Divulged |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
Subject is engaged in Developing, Manufacturing and Marketing a Broad Range of Pharmaceutical Products in India [Registered Activity] |
|
|
|
|
No. of Employees
: |
Not Divulged |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A+ |
|
Credit Rating |
Explanation |
Rating Comments |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
Maximum Credit Limit : |
USD 6185000 |
|
|
|
|
Status : |
Excellent |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Exist |
|
|
|
|
Comments : |
Subject was incorporated in the year 2002. It is a part of
the Emcure group. It is engaged in manufacturing and marketing of allopathic
pharmaceutical products.
|
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.09.2017) |
Current Rating (31.12.2017) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EXTERNAL AGENCY RATING
|
Rating Agency Name |
CARE |
|
Rating |
Long Term Bank Facilities= A+ |
|
Rating Explanation |
Adequate degree of safety and low credit
risk. |
|
Date |
09.10.2017 |
|
Rating Agency Name |
CARE |
|
Rating |
Short Term Bank Facilities= A1 |
|
Rating Explanation |
Very strong degree of safety and carry
lowest credit risk. |
|
Date |
09.10.2017 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter in
the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2018.
BIFR (Board for Industrial & Financial Reconstruction) LISTING
STATUS
Subject’s name is not listed as a Sick Unit in
the publicly available BIFR (Board for Industrial & Financial
Reconstruction) list as of 24.05.2018
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
INFORMATION DECLINED
MANAGEMENT NON-COOPERATIVE [Accounts Department] [91-20-27120084/
91-22-30610000]
LOCATIONS
|
Registered Office : |
T-184, M.I.D.C., Bhosari, Pune – 411026, Maharashtra, India |
|
Tel. No.: |
91-20-27120084 |
|
Fax No.: |
91-20-24117111 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Head / Marketing Office : |
Office No. 5119, 5th Floor, 'D' Wing, Oberoi Garden Estates, Chandivili, Andheri (East), Mumbai - 400 072, Maharashtra, India |
|
Tel. No.: |
91-22-30610000 / 28472823 / 24 |
|
Fax No.: |
91-22-28472828 / 29 |
|
E-Mail : |
DIRECTORS
AS ON: 31.03.2017
|
Name : |
Mr. Prakash Kumar Guha |
|||||||||||||||||||
|
Designation : |
Managing Director |
|||||||||||||||||||
|
Address : |
Building No.B4, Flat No. 505 Raunak Park, Konkani Pada, Pokharan Road No.
2, Thane – 400608, Maharashtra, India |
|||||||||||||||||||
|
Date of Birth/Age : |
27.03.1964 |
|||||||||||||||||||
|
Qualification : |
B.SC,MBA, LLB |
|||||||||||||||||||
|
PAN No.: |
ADPPG2715G |
|||||||||||||||||||
|
Date of Appointment : |
15.07.2012 |
|||||||||||||||||||
|
DIN No.: |
00118415 |
|||||||||||||||||||
|
Other Directorship:
|
||||||||||||||||||||
|
|
|
|||||||||||||||||||
|
Name : |
Mr. Satish Ramanlal Mehta |
|||||||||||||||||||
|
Designation : |
Director |
|||||||||||||||||||
|
Address : |
4, Mumbai - Pune Road, Kirkee, Pune-411003, Maharashtra, India |
|||||||||||||||||||
|
Date of Birth/Age : |
13.01.1951 |
|||||||||||||||||||
|
Qualification : |
M. S C., PGDM(IIMA) |
|||||||||||||||||||
|
Date of Appointment : |
03.07.2002 |
|||||||||||||||||||
|
DIN No.: |
00118691 |
|||||||||||||||||||
|
||||||||||||||||||||
|
|
|
|||||||||||||||||||
|
Name : |
Mr. Hitesh Sohanlal Jain |
|||||||||||||||||||
|
Designation : |
Director |
|||||||||||||||||||
|
Address : |
Alka Co-Op Housing Society 'B' Road, Flat 13, 2nd Floor, 40 Marine Drive Mumbai-400020, Mharashtra, India |
|||||||||||||||||||
|
Date of Birth/Age : |
20.10.1973 |
|||||||||||||||||||
|
Qualification : |
LLM |
|||||||||||||||||||
|
Date of Appointment : |
18.05.2009 |
|||||||||||||||||||
|
DIN No.: |
00130023 |
|||||||||||||||||||
|
||||||||||||||||||||
|
|
|
|||||||||||||||||||
|
Name : |
Mr. Shreekant Krushnaji Bapat |
|||||||||||||||||||
|
Designation : |
Director |
|||||||||||||||||||
|
Address : |
Yashodhan,2nd Floor, 56, United, Western Co-Op, Hsg, Soc. Karve Nagar, Pune-411052, Maharashtra, India |
|||||||||||||||||||
|
Date of Appointment : |
03.07.2002 |
|||||||||||||||||||
|
DIN No.: |
00621568 |
|||||||||||||||||||
|
||||||||||||||||||||
|
|
|
|||||||||||||||||||
|
Name : |
Mrs. Namita Vikas Thapar |
|||||||||||||||||||
|
Designation : |
Director |
|||||||||||||||||||
|
Address : |
Prasanna Bunglow No. 4, Mumbai-Pune Road Khadki, Pune-411003, Maharashtra, India |
|||||||||||||||||||
|
Date of Appointment : |
03.07.2012 |
|||||||||||||||||||
|
DIN No.: |
05318899 |
|||||||||||||||||||
|
||||||||||||||||||||
KEY EXECUTIVES
|
Name : |
Ms. Shilpa Uday Dhavale |
|
Designation : |
Secretary |
|
Address : |
C 302, Sai Marigold Society, Pimple Saudagar, Pune - 411028, Maharashtra, India |
|
Date of Birth/Age : |
01.04.1984 |
|
Qualification : |
B. Com, Company Secretary |
|
Date of Appointment : |
29.06.2015 |
|
PAN No.: |
ATIPD0060E |
|
|
|
|
Name : |
Mr. Raju Pessumal Kalera |
|
Designation : |
Chief Financial Officer |
|
Address : |
Building C1 Flat No. 202, SND 592a, CTS 3336, Mandke Advantage Homes, Lullanagar, Pune - 411040, Maharashtra, India |
|
Date of Appointment : |
01.11.2014 |
|
PAN No.: |
AGOPK9902F |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON: 31.03.2017
|
Names of Shareholders |
|
No. of Shares |
|
Prakashkumar Prasanta Guha |
|
2511000 |
|
Shriram Balasubramaniam |
|
300000 |
|
Chandrakant Vittal Shetty |
|
300000 |
|
Satish Ramlala Mehta |
|
63060 |
|
Sunil Rajanikant Mehta |
|
10560 |
|
Sanjay Rajanikant Mehta |
|
10560 |
|
Emcure Pharmaceuticals Limited, India |
|
15960000 |
|
Michael Jacob Mascarenhas |
|
300000 |
|
Roony Subroto Jena |
|
300000 |
|
Kamal Kapoor |
|
300000 |
|
|
|
|
|
Total |
|
20055180 |
AS ON: 08.08.2017
|
Equity Share Breakup |
Percentage of Holding |
|
Category |
|
|
Promoters – Body Corporate |
79.58 |
|
Public/Other than promoters – Individual/ Hindu Undivided
Family – Indian |
20.42 |
|
|
|
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Subject is engaged in Developing, Manufacturing and Marketing a Broad Range of Pharmaceutical Products in India [Registered Activity] |
||||
|
|
|
||||
|
Products : |
|
||||
|
|
|
||||
|
Brand Names : |
Not Available |
||||
|
|
|
||||
|
Agencies Held : |
Not Available |
||||
|
|
|
||||
|
Exports : |
Not Divulged |
||||
|
|
|
||||
|
Imports : |
Not Divulged |
||||
|
|
|
||||
|
Terms : |
|
||||
|
Selling : |
Not Divulged |
||||
|
|
|
||||
|
Purchasing : |
Not Divulged |
PRODUCTION STATUS: NOT AVAILABLE
GENERAL INFORMATION
|
Suppliers : |
|
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
Customers : |
|
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
No. of Employees : |
Not Divulged |
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
Bankers : |
Axis Bank Limited |
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
Facilities : |
|
|
|
|
|
Auditors : |
|
|
Name : |
Price Waterhouse Chartered Accountants |
|
Address : |
7th Floor, Business Bay, Tower A, Wing-1, Airport Road, Yerwada, Pune – 411006, Maharashtra, India |
|
PAN No.: |
AAEFP3641G |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Holding company: |
Emcure Pharmaceuticals Limited
[U24231PN1981PLC024251] |
|
|
|
|
Enterprise over which Key Management Personnel
have significant influence |
H.M. Sales Corporation |
|
|
|
|
Fellow Subsidiary : |
Gennova Biopharmaceuticals Limited |
CAPITAL STRUCTURE
AS ON: 31.03.2017
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
25000000 |
Equity Shares |
INR 10/- each |
INR 250.000 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
20055180 |
Equity Shares |
INR 10/- each |
INR 200.552
Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in INR Million]
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
200.552 |
200.552 |
200.552 |
|
(b) Reserves & Surplus |
1964.387 |
1577.686 |
1417.515 |
|
(c) Money received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share
Application money pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
2164.939 |
1778.238 |
1618.067 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) Long-term borrowings |
608.872 |
0.000 |
0.000 |
|
(b) Deferred tax liabilities (Net) |
0.000 |
0.000 |
0.000 |
|
(c)
Other long term liabilities |
35.650 |
30.650 |
28.450 |
|
(d)
long-term provisions |
46.235 |
45.040 |
39.621 |
|
Total
Non-current Liabilities (3) |
690.757 |
75.690 |
68.071 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a)
Short term borrowings |
168.086 |
96.204 |
113.362 |
|
(b)
Trade payables |
443.729 |
350.896 |
339.112 |
|
(c)
Other current liabilities |
748.162 |
268.384 |
150.037 |
|
(d)
Short-term provisions |
402.656 |
482.649 |
196.163 |
|
Total
Current Liabilities (4) |
1762.633 |
1198.133 |
798.674 |
|
|
|
|
|
|
TOTAL |
4618.329 |
3052.061 |
2484.812 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a)
Fixed Assets |
|
|
|
|
(i)
Tangible assets |
2022.717 |
421.508 |
445.207 |
|
(ii)
Intangible Assets |
3.860 |
2.145 |
1.027 |
|
(iii)
Capital work-in-progress |
107.084 |
211.466 |
17.866 |
|
(iv) Intangible assets under development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current
Investments |
450.588 |
458.723 |
450.407 |
|
(c) Deferred tax assets
(net) |
51.750 |
108.640 |
0.659 |
|
(d) Long-term Loan
and Advances |
0.000 |
0.000 |
101.883 |
|
(e)
Other Non-current assets |
157.252 |
196.494 |
4.015 |
|
Total
Non-Current Assets |
2793.251 |
1398.976 |
1021.064 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a)
Current investments |
0.000 |
0.000 |
0.000 |
|
(b)
Inventories |
949.091 |
788.490 |
671.094 |
|
(c)
Trade receivables |
605.889 |
590.211 |
579.297 |
|
(d)
Cash and cash equivalents |
39.909 |
92.447 |
113.784 |
|
(e)
Short-term loans and advances |
0.000 |
0.000 |
96.371 |
|
(f)
Other current assets |
230.189 |
181.937 |
3.202 |
|
Total
Current Assets |
1825.078 |
1653.085 |
1463.748 |
|
|
|
|
|
|
TOTAL |
4618.329 |
3052.061 |
2484.812 |
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
|
|
SALES |
|
|
|
|
|
|
|
Revenue from Operations |
6709.970 |
6313.041 |
5538.682 |
|
|
|
Other Income |
(2.517) |
35.051 |
4.999 |
|
|
|
TOTAL |
6707.453 |
6348.092 |
5543.681 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of Materials Consumed |
695.068 |
683.373 |
616.184 |
|
|
|
Purchases of Stock-in-Trade |
2018.102 |
1932.865 |
1836.226 |
|
|
|
Changes in inventories of finished goods, work-in-progress
and Stock-in-Trade |
(133.015) |
(25.489) |
(11.063) |
|
|
|
Employees benefits expense |
1339.467 |
1128.778 |
983.225 |
|
|
|
Other expenses |
1989.250 |
1709.569 |
1389.612 |
|
|
|
CSR Expenditure |
0.000 |
0.000 |
1.935 |
|
|
|
TOTAL |
5908.872 |
5429.096 |
4816.119 |
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION |
798.581 |
918.996 |
727.562 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
31.804 |
12.313 |
13.510 |
|
|
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
766.777 |
906.683 |
714.052 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
59.899 |
48.112 |
53.337 |
|
|
|
|
|
|
|
|
|
|
PROFIT/ (LOSS)
BEFORE TAX |
706.878 |
858.571 |
660.715 |
|
|
|
|
|
|
|
|
|
Less |
TAX |
196.947 |
255.733 |
201.906 |
|
|
|
|
|
|
|
|
|
|
PROFIT/ (LOSS)
AFTER TAX |
509.931 |
602.838 |
458.809 |
|
|
|
|
|
|
|
|
|
|
Earnings/ (Loss)
Per Share (INR) |
25.43 |
30.06 |
22.88 |
|
CURRENT MATURITIES OF LONG TERM DEBT DETAILS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Maturities of Long term debt |
102.083 |
0.000 |
0.000 |
|
|
|
|
|
|
Cash generated from operations |
NA |
NA |
NA |
|
|
|
|
|
|
Net cash flows from (used in) operations |
685.913 |
925.012 |
679.608 |
|
|
|
|
|
|
Net cash flows from (used in) operating activities |
470.025 |
680.290 |
453.162 |
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Average Collection Days (Sundry
Debtors / Income * 365 Days) |
32.96 |
34.12 |
38.18 |
|
|
|
|
|
|
Account Receivables Turnover (Income / Sundry Debtors) |
11.07 |
10.70 |
9.56 |
|
|
|
|
|
|
Average Payment Days (Sundry Creditors / Purchases * 365 Days) |
59.69 |
48.95 |
50.47 |
|
|
|
|
|
|
Inventory Turnover (Operating Income / Inventories) |
0.84 |
1.17 |
1.08 |
|
|
|
|
|
|
Asset Turnover (Operating Income / Net Fixed Assets) |
0.37 |
1.45 |
1.57 |
LEVERAGE RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Debt Ratio ((Borrowing
+ Current Liabilities) / Total Assets) |
0.54 |
0.39 |
0.32 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability / Networth) |
0.41 |
0.05 |
0.07 |
|
|
|
|
|
|
Current Liabilities to Networth (Current Liabilities / Net Worth) |
0.81 |
0.67 |
0.49 |
|
|
|
|
|
|
Fixed Assets to Networth (Net Fixed Assets / Networth) |
0.99 |
0.36 |
0.29 |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT / Financial Charges) |
25.11 |
74.64 |
53.85 |
PROFITABILITY RATIOS
|
PARTICULARS |
|
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Net Profit Margin ((PAT / Sales) * 100) |
% |
7.60 |
9.55 |
8.28 |
|
|
|
|
|
|
|
Return on Total Assets ((PAT / Total Assets) * 100) |
% |
11.04 |
19.75 |
18.46 |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT / Networth) * 100) |
% |
23.55 |
33.90 |
28.36 |
SOLVENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Ratio (Current
Assets / Current Liabilities) |
1.04 |
1.38 |
1.83 |
|
|
|
|
|
|
Quick Ratio ((Current Assets – Inventories) / Current
Liabilities) |
0.50 |
0.72 |
0.99 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth / Total Assets) |
0.47 |
0.58 |
0.65 |
|
|
|
|
|
|
G-Score Ratio Debt (Debts / Equity Capital) |
4.38 |
0.48 |
0.57 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total Current Assets / Total Current Liabilities) |
1.04 |
1.38 |
1.83 |
Total
Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term
debts
FINANCIAL ANALYSIS
[all figures are
in INR Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Share Capital |
200.552 |
200.552 |
200.552 |
|
Reserves & Surplus |
1417.515 |
1577.686 |
1964.387 |
|
Money received against share
warrants |
0.000 |
0.000 |
0.000 |
|
Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Net
worth |
1618.067 |
1778.238 |
2164.939 |
|
|
|
|
|
|
long-term borrowings |
0.000 |
0.000 |
608.872 |
|
Short term borrowings |
113.362 |
96.204 |
168.086 |
|
Current Maturities of Long
term debt |
0.000 |
0.000 |
102.083 |
|
Total
borrowings |
113.362 |
96.204 |
879.041 |
|
Debt/Equity
ratio |
0.070 |
0.054 |
0.406 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Sales |
5538.682 |
6313.041 |
6709.970 |
|
|
|
13.981 |
6.287 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Sales |
5538.682 |
6313.041 |
6709.970 |
|
Profit/ (Loss) |
458.809 |
602.838 |
509.931 |
|
|
8.28% |
9.55% |
7.60% |
LEGAL CASES
|
CITY CIVIL AND SESSIONS COURT, AHMEDABAD CASE DETAILS Case Type: Comm TM CS Filing Number: 32/2017Filing Date: 16-06-2017 Registration Number: 32/2017Registration Date: 16-06-2017 CNR Number: GJAH02-007712-2017 CASE STATUS First Hearing Date: 16th June 2017 Next Hearing Date: 08th September 2017 Date Not Updated Stage of Case: HEARING Court Number and Judge: 3-JUDGE COMMERCIAL COURT PETITIONER AND ADVOCATE 1) ERIS LIFESCIENCES PRIVATE LIMITED
RESPONDENT AND ADVOCATE 1)
ZUVENTUS HEALTHCARE LIMITED ACTS
HISTORY OF CASE HEARING
|
|
CITY CIVIL AND SESSIONS COURT, AHMEDABAD CASE DETAILS Case Type: Comm TM CS - Commercial Trademark Civil Sui Filing Number: 16/2017Filing Date: 24-01-2017 Registration Number: 16/2017Registration Date: 24-01-2017 CNR Number: GJAH02-007192-2017
CASE STATUS First Hearing Date: 06th June 2017 Next Hearing Date: 28th June 2017 Stage of Case: HEARING Court Number and Judge: 3-JUDGE COMMERCIAL COURT PETITIONER AND ADVOCATE 1) ERIS LIFESCIENCES PRIVATE
LIMITED RESPONDENT AND ADVOCATE 1)
ZUVENTUS HEALTHCARE LIMITED ACTS
ORDERS
CASE TRANSFER DETAILS BETWEEN THE COURTS
|
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in Report
(Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
No |
|
5 |
Buyer visit details |
-- |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
Yes |
|
8 |
Designation of contact person |
Yes |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
Yes |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
No |
|
16 |
No. of employees |
No |
|
17 |
Details of sister concerns |
Yes |
|
18 |
Major suppliers |
No |
|
19 |
Major customers |
No |
|
20 |
Banking Details |
Yes |
|
21 |
Banking facility details |
Yes |
|
22 |
Conduct of the banking account |
-- |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
Yes |
|
26 |
Turnover of firm for last three years |
Yes |
|
27 |
Reasons for variation <> 20% |
-- |
|
28 |
Estimation for coming financial year |
No |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
Yes |
|
31 |
External Agency Rating, if available |
Yes |
|
32 |
Litigations that the firm/promoter
involved in |
Yes |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
No |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
INDEX OF CHARGES
|
CHARGES REGISTERED |
||||||||
|
SNO |
SRN |
CHARGE ID |
CHARGE HOLDER NAME |
DATE OF CREATION |
DATE OF MODIFICATION |
DATE OF SATISFACTION |
AMOUNT |
ADDRESS |
|
1 |
G84263474 |
100170095 |
AXIS BANK LIMITED |
19/03/2018 |
- |
- |
200000000.0 |
214-215, CITY MALL, 2ND , PLOT NO. 1, S.NO.132,GANESH KHIND ROAD(UNIVERSITY ROAD),PUNEMH411007IN |
|
2 |
G82713496 |
100166669 |
HDFC BANK LIMITED |
01/02/2018 |
- |
- |
1150000.0 |
HDFC BANK HOUSE SENAPATI BAPAT MARGLOWER PAREL WESTMUMBAIMH400013IN |
|
3 |
G68220094 |
100136743 |
HDFC BANK LIMITED |
14/11/2017 |
- |
- |
675000.0 |
HDFC BANK HOUSE SENAPATI BAPAT MARGLOWER PAREL WESTMUMBAIMH400013IN |
|
4 |
G68244607 |
100136786 |
HDFC BANK LIMITED |
08/11/2017 |
- |
- |
950000.0 |
HDFC BANK HOUSE SENAPATI BAPAT MARGLOWER PAREL WESTMUMBAIMH400013IN |
|
5 |
G60550415 |
100131869 |
HDFC BANK LIMITED |
28/09/2017 |
- |
- |
1090000.0 |
HDFC BANK HOUSE SENAPATI BAPAT MARGLOWER PAREL WESTPUNEMH400013IN |
|
6 |
G54390737 |
100106080 |
AXIS BANK LIMITED |
12/06/2017 |
19/09/2017 |
- |
700000000.0 |
214-215, CITY MALL, 2ND , PLOT NO. 1, S.NO.132,GANESH KHIND ROAD(UNIVERSITY ROAD),PUNEMH411007IN |
|
7 |
G72950645 |
100106031 |
AXIS BANK LIMITED |
12/06/2017 |
15/12/2017 |
- |
200000000.0 |
CORPORATE BANKING BRANCH, 214/215 CITY MALL,NEAR PUNE UNIVERSITY, GANESHKHIND ROADPUNEMH411007IN |
|
8 |
G43776764 |
100097245 |
HDFC BANK LIMITED |
24/04/2017 |
- |
- |
2400000.0 |
HDFC BANK HOUSE SENAPATI BAPAT MARGLOWER PAREL WESTMUMBAIMH400013IN |
|
9 |
G37204401 |
100080724 |
HDFC BANK LIMITED |
16/02/2017 |
- |
- |
1200000.0 |
HDFC BANK HOUSE SENAPATI BAPAT MARGLOWER PAREL WESTMUMBAIMH400013IN |
|
10 |
G28252385 |
100063606 |
HDFC BANK LIMITED |
24/10/2016 |
- |
- |
735000.0 |
HDFC BANK HOUSE SENAPATI BAPAT MARGLOWER PAREL WESTMUMBAIMH400013IN |
GENERAL
INFORMATION:
Zuventus
Healthcare Limited (hereinafter referred to as "Company") is a company
limited by shares, incorported and domiciled in India. The Company has its own
manufacturing facility in Jammu,Sikkim and Bangalore. The Company is engaged in
developing, manufacturing and marketing a broad range of pharmaceutical
products in India.
RESULTS OF OPERATIONS
The
Company has achieved gross revenue of INR 6709.97 million and the operating
profit before finance costs, depreciation & amortization and tax was INR
798.58 million as compared to INR 919.01 million in the previous year
FIXED ASSETS:
·
Land
·
Building
·
Plant and Machinery
·
Furniture and Fixture
·
Office Equipment
·
Computer
·
Vehicles
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources including
but not limited to: The Courts, India Prisons Service, Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist organization
or whom notice had been received that all financial transactions involving
their assets have been blocked or convicted, found guilty or against whom a
judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
INR |
|
US Dollar |
1 |
INR 68.21 |
|
UK Pound |
1 |
INR 91.43 |
|
Euro |
1 |
INR 80.24 |
INFORMATION DETAILS
|
Information
Gathered by : |
SHA |
|
|
|
|
Analysis Done by
: |
PRY |
|
|
|
|
Report Prepared
by : |
RUP |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
YES |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as
a reference to assess SC’s credit risk and to set the amount of credit to be
extended. It is calculated from a composite of weighted scores obtained from
each of the major sections of this report. The assessed factors are as follows:
·
Financial condition covering various ratios
·
Company background and operations size
·
Promoters / Management background
·
Payment record
·
Litigation against the subject
·
Industry scenario / competitor analysis
·
Supplier / Customer / Banker review (wherever
available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.